Cambridge Investment Research Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-13,082
| Closed | -$37K | – | 2551 |
|
|
2020
Q1 | $37K | Buy |
+13,082
| New | +$37K | ﹤0.01% | 2208 |
|
|
2018
Q4 | – | Sell |
-12,704
| Closed | -$33K | – | 2364 |
|
|
2018
Q3 | $33K | Sell |
12,704
-4,773
| -27% | -$12.4K | ﹤0.01% | 2210 |
|
|
2018
Q2 | $41K | Sell |
17,477
-10,546
| -38% | -$24.7K | ﹤0.01% | 2169 |
|
|
2018
Q1 | $82K | Sell |
28,023
-3,888
| -12% | -$11.4K | ﹤0.01% | 2071 |
|
|
2017
Q4 | $87K | Sell |
31,911
-9,117
| -22% | -$24.9K | ﹤0.01% | 2038 |
|
|
2017
Q3 | $139K | Sell |
41,028
-94
| -0.2% | -$318 | ﹤0.01% | 1890 |
|
|
2017
Q2 | $102K | Sell |
41,122
-4,844
| -11% | -$12K | ﹤0.01% | 1848 |
|
|
2017
Q1 | $104K | Buy |
45,966
+104
| +0.2% | +$235 | ﹤0.01% | 1694 |
|
|
2016
Q4 | $97K | Buy |
45,862
+7,194
| +19% | +$15.2K | ﹤0.01% | 1590 |
|
|
2016
Q3 | $130K | Buy |
38,668
+3,357
| +10% | +$11.3K | ﹤0.01% | 1646 |
|
|
2016
Q2 | $111K | Sell |
35,311
-38,788
| -52% | -$122K | ﹤0.01% | 1474 |
|
|
2016
Q1 | $247K | Buy |
74,099
+731
| +1% | +$2.44K | 0.01% | 1280 |
|
|
2015
Q4 | $260K | Sell |
73,368
-5,073
| -6% | -$18K | 0.01% | 1195 |
|
|
2015
Q3 | $395K | Buy |
78,441
+6,256
| +9% | +$31.5K | 0.01% | 886 |
|
|
2015
Q2 | $464K | Buy |
72,185
+48,282
| +202% | +$310K | 0.01% | 850 |
|
|
2015
Q1 | $168K | Buy |
+23,903
| New | +$168K | ﹤0.01% | 1287 |
|